Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
The neurotransmitter dopamine controls numerous physiological functions in the brain and periphery via dopamine receptors in the G-protein-coupled receptor superfamily. Five dopamine receptors (DRD1-DRD5) are found in humans and DRD2 plays important pharmacological roles in numerous human disorders related to dopaminergic dysfunction, such as schizophrenia and Parkinson’s disease. In this study, we generate the functional antibody, which specifically recognizes DRD2, and we determined the ligand-free DRD2 structure using this antibody. This structure is believed to clarify the drug binding mechanism by comparison with already known antipsychotics binding structures. We also believe that it can help understand the mechanism of dopaminergic dysfunction.
|